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ABSTRACT
Bauhinia cheilantha (Leguminosae: Caesalpinioideae) is a common plant of the Brasilian Caatinga widely used in folk medicine
as an analgesic. In order to verify this effect pharmacologically, the antinociceptive activity of the plant was evaluated through the
administration of its aqueous extract in mice. The extract was administered orally (400 mg/kg) 60 minutes before a writhing test,
and was found to reduce nociception by 54.4%. The effects of formalin (1%) were also reduced by the extract at all doses.
Naloxone (5 mg/kg, i.p.) and caffeine (10 mg/kg, i.p) reverted the effect of the extract. In a hot plate test, the extract (100mg,
200mg and 400 mg/kg) increased latency time by 39.8%, 30.7% and 32.8%, respectively.  There was no acute toxicity in doses
up to 3g/kg.  The aqueous extract of the B. cheilantha bark revealed antinociceptive activity in all the models tested, effects that
are possibly associated with the opioid and adenosine systems.
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RESUMO
Bauhinia cheilantha (Leguminosae-Caesalpinioideae) é uma planta comum da caatinga amplamente utilizada na medicina popular
como analgésica. Para verificar farmacologicamente este efeito, a atividade antinociceptiva desta planta foi verificada através do
extrato aquoso da entre-casca, administrado em camundongos. O extrato (400 mg/kg), administrado por via oral 60 minutos antes
do teste reduziu a nocicepção em 54,4%. Os efeitos da formalina (1%) também foram reduzidos pelo extrato em todas as doses.
Naloxona (5 mg/kg, i.p.) e cafeína (10 mg/kg, i.p) também reverteram este efeito.  No teste da placa quente o extrato de B.
cheilantha  nas doses 100mg, 200mg e 400 mg/kg, aumentou o tempo de latência  em 39.8%, 30.7% e 32.8%, respectivamente.
 Não houve toxicidade aguda até a dose de 3g/Kg. O extrato aquoso da entre-casca de B. cheilantha  mostrou atividade antinociceptiva
nos modelos testados, efeito possivelmente associado com os sistemas opióide e adenosina.
Palavras-chave: Bauhinia cheilanta, antinociceptivo, extrato aquoso.
INTRODUCTION
Many plants of the Brasilian flora are used in
local folk medicine, but very few have been
pharmacologicaly validated. Among the unstudied
majority is the legume Bauhinia cheilantha (Bong.)
Steud., a small tree (average height 5 m), which is
relatively common in the semi-arid Brasilian Caatinga.
Known locally as mororó , the extract of its bark is used
as an analgesic, but there are no pharmacological data
on its properties.
A variety of pharmacological properties have
been reported for species of the genus Bauhinia. For
example, the seeds of Bauhinia monandra  affect
haemagglutination positively, although this effect is
eliminated by autoclaving (Abreu et al, 1990;  Penate et
al, 1988), and the leaves of Bauhinia tarapotensis have
antioxidant properties (Braca et al., 2001). Other species
of the genus Bauhinia  have been reported to have
properties related to the treatment of malaria and
hypoglycemia, and the regulation of thyroid hormones
(Kittakoop et al., 2000; Lemus et al., 1999; Pepato et al.,
2002; Panda & Kar, 1999).
Several chemical compounds have been
purified from different species of Bauhinia, including
lectins, racemosol, and demethylracemosol. (Silva &
Filho, 2002; Allen et al., 1980, Kittakoop et al., 2000).
The medicinal uses of B. cheilantha have been reported
in the ethnobotanical literature (eg. Andrade-Lima,
1988), but there have been no pharmacological studies
of the analgeic properties of this plant, a lack of
information which motivated the present study.
MATERIAL AND METHODS
Plant material: Bark of B. cheilantha was collected
during the wet season in the village of Santa Rosa do
Ermírio, Sergipe (09°45’S, 37°40’W). The species was
identified by the biologist Gilvane V. Souza, and the
voucher specimen (number 007490) is deposited at the
herbarium of the Departamento de Biologia,
Universidade Federal de Sergipe, Brasil.
Preparation of aqueous extract (AE): The bark was
dried at 40°C in a forced air oven (Marconi MA 037) for
48 h and triturated in a mill to obtain a powder. This
powder was added to distilled water (1:5 w/v) at 75°C
and infused for 30 min in order to constitute the
aqueous extract. After infusion, the AE was filtered
and freeze dried in a VirTis bench top freeze dryer,
yielding a brown powder (8%), which was diluted and
used in the pharmacological tests.  For the experiments,
the extract was reconstituted in water at three different
concentrations – 100 mg/mL (AE100), 200 mg/mL
(AE200) and 400 mg/mL (AE400), which were
administered orally to the mice 60 minutes before each
experiment.
Animals: Male and female Swiss mice (20-35 g) were
used as test animals.  The animals were maintained in
plastic cages, with food and water ad libitum, but were
fasted for 12 hours prior to the oral administration of
test substances. All experiments were performed in
accordance with current guidelines for the care of
laboratory animals and ethical guidelines for
investigations of experimental pain in conscious
animals.
Preparation of drugs: Drugs used in the experiments
were diluted to an injection volume of 0.1 mL/10g of
animal weight, except when defined in the text. Acetic
acid 0.6% (Merck), morphine hydrochloride (Sigma),
formalin 1% (Baker), naloxone hydrochloride (Sigma),
and caffeine (Sigma) were all diluted in water.
Indomethacin (Sigma) was diluted in water/0.1 N NaOH
(pH = 8). Indomethacin, morphine, naloxone and
caffeine were injected 15 minutes before tests.
Acute toxicity: Acute toxicity
 
of the plant was verified
in three groups of mice (n = 5/ne group (n = 5) received
distilled water; the others received the aqueous extract
in increasing doses (1, 2, and 3 g/kg; p.o.).  The mortality
was observed during 48 hours.
Pharmacological tests
Antinociceptive activity was verified using the
writhing test induced by acetic acid 0.6% (Koster et al.
1959), the formalin 1% test (Dubuisson et al., 1977;
Hunskaar, 1986) and the hot plate test (Eddy &
Leimbach, 1953).
Writhing test: Six groups of mice (n = 9) were
tested. All animals received acetic acid 0.6% (0.1 mL/
10g; i.p.), and AE100, AE200 and AE400 was
administered p.o. to three groups 1 h before the
nociceptive agent. One control group received distilled
water instead of the aqueous extract. Morphine (2.5
mg/kg, i.p.) and indomethacin (10 mg/kg, i.p.) were used
as standards in the remaining groups. Ten minutes after
the acid was administrated, the number of writhes was
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recorded during a period of 20 min.
Hot plate test: The experiment started 60 min
(time zero) after p.o. administration of AE100, AE200
and AE400. The mice (n = 9) were placed on an aluminum
plate heated to 55±0.5ºC and the time elapsed to the
moment when they licked their hind paws was recorded
(hereafter referred to as latency). This procedure was
repeated at times 0, 15, 30 and 60 min. In order to avoid
damage to the paws of the animals, time standing on
the plate was limited to 30 seconds.  Morphine (5 mg/
kg, i.p.) was used as the reference drug.
Formalin test: In a group of nine mice, AE100,
AE200 and AE400 was administered p.o., and after 60
min., 0.02 mL of 1% formalin was administered to the
subplantar of the left posterior paw. The time that each
mouse spent licking its paw was recorded. Control
animals received distilled water, p.o. Morphine was
used as a standard test drug (7.5 mg/kg, i.p.). The
reaction to pain was measured 0-5 min (1st phase) and
20-25 min (2nd phase) after administration of the
stimulus. In order to confirm the possible participation
of the opioid system, naloxone (5 mg/kg; i.p.) was
administered with AE100 to a second group (n = 8).
Morphine combined with naloxone (7.5 mg/kg, i.p. and
5 mg/kg; i.p., respectively) was administered to a third
group 15 minutes prior to the injection of formalin. We
also administered caffeine (10 mg/kg, i.p.) associated
with AE100 to verify the influence of the adenosine
system on the effect of the aqueous extract.
Statistical analysis: Results of the hot plate test were
analysed using two-factor parametric ANOVA, in which
the variable was the latency and the two factors being
simultaneously verified were the time interval of the
four experiments and the drugs (extract and morphine
dosage, and the control). The Tukey test for multiple
comparisons of the means was applied to all F values
with p<0.05. The results of the writhing and formalin
tests were analysed using the Kruskal-Wallis non-
parametric one-way ANOVA (samples do not come from
normal population and the variances are heterogenous),
with the Nemenyi test for multiple comparisons of the
medians (Zar, 1996).
Percentage inhibition = (1-Vt/Vc) x 100, where Vt
and Vc represent the number of writhes or time spent
licking the paw for the treated and control groups,
respectively.  The percentage increase in latency = (1-
(Xc/Xt)x 100), where Xc and Xt are the average latency
for control and treated groups, respectively.
RESULTS AND DISCUSSION
The aqueous extract of B. cheilantha reduced
significantly the frequency of writhing induced by acetic
acid (Kruskal-Wallis: F
0,05;5;47 
= 32.4; p<0.0005), with the
number of events reduced by up to 54.4%, in
comparison with the control, at 400 mg/kg (Nemenyi:
q
0,05;¥;6 
= 5.1; p<0.05, Table 1). Positive results for the
writhing test do not necessarily means that the extract
has an analgesic effect, however, as this test is
sensitive not only to analgesics, but also to substances
such as muscle relaxants, antihistamines, monoamine
oxidase inhibitors, adrenergic blockers, and neuroleptics
(Chernov et al., 1967; Hendershot & Forsaith,  1959;
Loux et al., 1978; Pearl et al., 1968). The formalin and
hot plate tests were employed in order to confirm the
analgesic properties of the extract.
The hot plate model involves a supraspinal
response to thermal stimuli.  Drugs with supraspinal
action affect this response, especially at temperatures
of 55ºC or more (Ankier, 1974; Magalini et al., 1979).
The results indicate no statistical difference in mean
latency among the experiments at time zero, 15, 30 and
60 min (ANOVA: F
0.05(1)3,140 
= 0.956; p>0,05; Table 2)
and no interaction of the experiments with drugs
(including control) affecting latency means  (F
0.05(1)12,140
=  0.735, p>0.05). These results indicate homogeneity
in the mean latency of control, morphine, and extract
groups in all four experiments, but the most important
general finding was the significant differences among
drugs (including control), independently of time
(ANOVA: F
0.05(1)4,140
 = 27.8; p< 0.0005).
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Table 1.  Effects of control, AE100, AE200, and AE400, 
indomethacin (10 mg/kg), and morphine (2.5 mg/kg) on the 
frequency of writhing induced by acetic acid 0.6%. 
Group Dose (mg/kg) Median % 
Control - 27 - 
Morphine 2.5 3* 69.2 
Indomethacin 10 2* 79.8 
AE 100 18 17.2 
AE 200 14 41.9 
AE 400 6* 54.4 
n = 9 
* p<0.05 compared to control, Nemenyi test after Kruskal-Wallis. 
% = percentage of writhes inhibition scores.  
 
 
Table 2.  Effects of B. cheilantha aqueous extract (AE) and morphine on latency time in the hot plate test. 
Latency time (Mean±SEM) Groups Dose 
(mg/kg) 0 min 15 min  30 min 60 min 
Grand 
Mean  
% 
Control - 13.11±1.02 13.25±1.29 9.55±1.15 8.73±1.33 11.16 - 
Morphine 5 29.09±0.91 25.66±2.17 27.52±1.26 25.59±1.83 26.96* 58.6 
AE 100 18.45±2.22 14.93±1.67 19.83±2.88 20.92±2.66 18.53* 39.8 
AE 200 15.78±1.56 14.71±2.51 17.5±2.70 16.4±2.57 16.1* 30.7 
AE 400 18.45±1.92 14.87±1.56 16.38±2.3 16.75±2.31 16.61* 32.8 
n = 9 for each group at each time interval. 
* p<0,05, compared to control, Tukey test after  two way ANOVA. 
%, percentage of latency time increase.  
SEM, standard error of the mean. 
 
The accentuated significance of this result may
be due primarily to the morphine effect, but we were
particularly interested in verifying the contribution of
the extract to the significance of the variance and which
dose affected the result. As no significant differences
were found among experiments, the grand mean of each
extract dose was compared to the grand mean of the
control. The results indicate that all doses of the extract
were significantly different from control, with an
increase of 39.8% (AE100), 30.7% (AE200) and 32.8%
(AE400) in latency of the response to the administration
of the extract. (Tukey: AE100, AE200, and AE400 vs.
control group, respectively: q
0.05,140,5
 = 6.74; p<0.05;
q
0.05,140,5
 = 4.51; p<0.05; q
0.05,140,5
 = 4.9; p<0.05; Table 2).
This response suggests that, like morphine, the
aqueous extract interferes with the central pain induced
mechanism, reducing its nociceptive response to
thermal stimuli.
The aqueous extract of B. cheilantha altered the
paw licking time significantly in both phases of the
test (Kruskal-Wallis: F
0.05(1)4;39 
= 15.3; p<0.0005; F
0.05(1)4;39
= 13.7; p<0.0005; respectively). In the first phase, AE100
reduced paw licking time significantly (Nemenyi: q
0.05,¥, 5
= 4.1; p<0.05).  In the second phase, all doses inhibited
the formalin effect (Nemenyi: q
0.05,¥,5, 
= 5.3; p<0.05;
q
0.05,¥,5
= 4.2; p<0.05; q
0.05,¥,5 
= 4.2; p<0.05).  Table 3 shows
the percentage inhibition of the pain reaction produced
by morphine and the plant’s aqueous extract.
Naloxone, a non-selective opioid receptor
antagonist, was used to elucidate the possible
mechanisms of the B. cheilantha extract (Magalini et
al., 1979).  In the first phase, Kruskal-Wallis revealed
no significant differences among the following groups:
control, morphine plus naloxone, and AE100 plus
naloxone (Kruskal-Wallis: F
0.05(1)2;20 
= 2.2; p>0.10, Table
4), which suggests that the effect of the aqueous extract
may involve an opioid system. However, when
comparing the control, AE100, and AE100 plus caffeine
groups, significant differences were found in both
phases of the test (Kruskal-Wallis: F
0.05(1)2,20 
= 13.2;
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Table 3.  Effect of B. cheilantha aqueous extract (AE, 100, 200, and 400 mg/kg) 
and morphine (7.5 mg/kg) in the 1% formalin test.   
1st phase 2nd phase 
Groups Dose (mg/kg) 
Median % Median % 
Control - 35 - 21 - 
Morphine 7.5 10* 77.4 0* 64.0 
AE 100 20* 53.9 0* 57.4 
AE 200 24 17.9 0* 46.1 
AE 400 29 -3.7 0* 46.2 
n = 9 for each group at each time interval  
* p<0.05 compared to control, Nemenyi test after Kruskal-Wallis. 
% = inhibition percentage of pain reaction scores. 
 
 
p<0.0005; F
0.05(1)2,20 
= 82.7; p<0.0005, respectively). In
the first phase, caffeine reverted the AE effect
(Nemenyi: q
0.05
,
¥;5 
= 1.8; p>0.05; Table 5), which indicates
participation of the adenosine system in the analgesic
effect.  Adenosine may interact with four subtypes of
receptors (A
1
,  A
2a
,  A
2b
 and A
3
), but, as caffeine is a
non-selective antagonist, further studies will be
necessary to determine how these subtypes are
involved in the response.
In order to evaluate the acute toxicity of B.
cheilantha , the mice were submmited to increasing
doses of the extract. No deaths ocurred, even at the
highest dose (3 mg/kg), indicating low toxicity, as
reported by Lorke (1993).
Table 4.  Effect of naloxone (5 mg/kg, i.p.) on morphine (10 
mg/kg, p.o.) and AE100 in the formalin test. 
1st phase 2nd phase 
Groups 
Median % Median % 
Control 54.5 - 29.5 
- 
Morphine + 
Naloxone 
55.5 -10.9 18 21.2 
AE100 + 
Naloxone 
47.5 38.2 0* 73.3 
n = 8 for each group at each tim e interval. 
*p<0.05 compared to control, Nemenyi test after Kruskal-Wallis . 
% = inhibition percentage of pain reaction scores 
 
Table 5.  Effects of caffeine on AE100 in the formalin test. 
1st phase 2nd phase Groups 
Median % Median % 
Control  
53.5 - 27.0 - 
AE100 23.5* 68.7 0.0* 56.1 
AE100 + 
Caffeine 
37.0 25.1 0.0* 61.0 
n = 8 for each group at each time interval. 
*p<0.05 compared to control, Nemenyi test after Kruskal-Wallis. 
% = inhibition percentage of pain reaction scores. 
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